Marc Goodman

MARC GOODMAN is an Executive Director of Morgan Stanley and is the
Specialty Pharmaceuticals Analyst covering small and mid-cap
pharmaceutical and drug delivery companies. Additionally, he covers
specialized medical technology companies with an optical focus. Mr.
Goodman joined MS in 1994. Prior to assuming his current
responsibilities, he worked on the MS team covering both large and mid-
cap pharmaceutical companies. Before joining MS, he was a buyside
analyst with Shearson Lehman Advisors. He received a BA from Tufts
University and an MBA from Ohio State University.